Pharma Partnerships
Scott discusses the complex relationship between pharmaceutical companies and the diabetes community, emphasizing the necessity of insulin production and the importance of funding for advocacy efforts. He reflects on the challenges of raising awareness in a saturated social media landscape, where voices can easily become lost in the noise. Ultimately, he advocates for a pragmatic approach to collaboration that benefits those living with diabetes.In this clip
From this podcast
Juicebox Podcast: Type 1 Diabetes
#395 Conversation with Cameron J. H.
Related Questions